Skip to main content
Consensus Study Report

VIEW LARGER COVER

Common diseases cost the developing world an enormous amount in terms of human life, health, and productivity, as well as lost economic potential. New and effective vaccines could not only improve the quality of life for millions of residents in developing countries, they could also contribute substantially to further economic development. Using data from the World Health Organization and other international agencies, this book analyzes disease burdens, pathogen descriptions, geographic distribution of diseases, probable vaccine target populations, alternative control measures and treatments, and future prospects for vaccine development. New Vaccine Development provides valuable insight into immunological and international health policy priorities.

Suggested Citation

Institute of Medicine. 1986. New Vaccine Development: Establishing Priorities: Volume II, Diseases of Importance in Developing Countries. Washington, DC: The National Academies Press. https://doi.org/10.17226/920.

Import this citation to:

Publication Info

448 pages |  8.5 x 11 |  Paperback
ISBN: 978-0-309-03679-5
DOI: https://doi.org/10.17226/920
Chapters skim
Front Matter i-xvi
1. Summary 1-18
2. Priority Setting for Health-Related Investments: A Review of Methods 19-29
3. Overview of the Analytic Approach 30-43
4. Comparison of Disease Burdens 44-62
5. Predictions of Vaccine Development 63-75
6. Assessing the Likely Utilization of New Vaccines 76-81
7. Calculation and Comparison of the Health Benefits and Differential Costs Associated with Candidate Vaccines 82-105
8. Additional Issues in the Selection of Priorities for Accelerated Vaccine Development 106-120
9. Findings, Conclusions, and Recommendations 121-142
Appendix A: Selection of Vaccine Candidates for Accelerated Development 143-148
Appendix B: The Burden of Disease Resulting from Acute Respiratory Illness 149-158
Appendix C: The Burden of Disease Resulting from Diarrhea 159-169
Appendix D-1: The Prospects for Immunizing Against Dengue Virus 170-177
Appendix D-2: The Prospects for Immunizing Against Escherichia coli 178-185
Appendix D-3: The Prospects for Immunizing Against Hemophilus influenzae Type b 186-196
Appendix D-4: The Prospects for Immunizing Against Hepatitis A Virus 197-207
Appendix D-5: The Prospects for Immunizing Against Hepatitis B Virus 208-222
Appendix D-6: The Prospects for Immunizing Against Japanese Encephalitis Virus 223-240
Appendix D-7: The Prospects for Immunizing Against Mycobacterium leprae 241-250
Appendix D-8: The Prospects for Immunizing Against Neisseria meningitidis 251-266
Appendix D-9: The Prospects for Immunizing Against Parainfluenza Viruses 267-274
Appendix D-10: The Prospects for Immunizing Against Plasmodium spp. 275-286
Appendix D-11: The Prospects for Immunizing Against Rabies Virus 287-298
Appendix D-12: The Prospects for Immunizing Against Respiratory Syncytial Virus 299-307
Appendix D-13: The Prospects for Immunizing Against Rotavirus 308-318
Appendix D-14: The Prospects for Immunizing Against Salmonella typhi 319-328
Appendix D-15: The Prospects for Immunizing Against Shigella spp. 329-337
Appendix D-16: The Prospects for Immunizing Against Streptococcus Group A 338-356
Appendix D-17: The Prospects for Immunizing Against Streptococcus pneumoniae 357-375
Appendix D-18: The Prospects for Immunizing Against Vibrio cholerae 376-389
Appendix D-19: The Prospects for Immunizing Against Yellow Fever 390-402
Appendix E: Questionnaire for Assessing Morbidity-Mortality Trade-Offs 403-411
Appendix F: Technical Notes 412-412
Appendix G: Biographical Notes on Committee Members 413-417
Appendix H: Additional Sources of Advice to the Committee 418-419
Appendix I: Contents of Supplement to Volume II 420-420
Appendix J: Preface to Volume I 421-422
Appendix K: Contents to Volume I 423-423
Index 424-432

What is skim?

The Chapter Skim search tool presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter. You may select key terms to highlight them within pages of each chapter.

Copyright Information

The National Academies Press (NAP) has partnered with Copyright Clearance Center's Marketplace service to offer you a variety of options for reusing NAP content. Through Marketplace, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Marketplace allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Marketplace you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the NAP through Marketplace:

  • Republish text, tables, figures, or images in print
  • Post on a secure Intranet/Extranet website
  • Use in a PowerPoint Presentation
  • Distribute via CD-ROM
  • Photocopy

Click here to obtain permission for the above reuses. If you have questions or comments concerning the Marketplace service, please contact:

Marketplace Support
International +1.978.646.2600
US Toll Free +1.855.239.3415
E-mail: support@copyright.com
marketplace.copyright.com

To request permission to distribute a PDF, please contact our Customer Service Department at customer_service@nap.edu.

loading iconLoading stats for New Vaccine Development: Establishing Priorities: Volume II, Diseases of Importance in Developing Countries...